Insiders · RAPT

RAPT insider transactions

RAPT Therapeutics Inc. (RAPT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RAPT

• 95d
  Director Lyons-Williams Lori closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  Director Gray Mary Ann closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  Director Giordano Michael F closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  Director Dombkowski Ashley L. closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  CHIEF FINANCIAL OFFICER Young Rodney Kb closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G. closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  PRESIDENT AND CEO Wong Brian Russell closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  Director Kozick Linda closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 95d
  Director Braunstein Scott closing all direct ownership in the company (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Braunstein Scott was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Giordano Michael F was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Gray Mary Ann was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Lyons-Williams Lori was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Kozick Linda was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 126d
  Director Dombkowski Ashley L. was granted 4,956 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 342d
  SEC Form 4 filed by Director Dombkowski Ashley L.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 342d
  SEC Form 3 filed by new insider Dombkowski Ashley L.

  3 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by Director Braunstein Scott

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 3 filed by new insider Braunstein Scott

  3 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by PRESIDENT AND CEO Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 349d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Giordano Michael F

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Lyons-Williams Lori

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 371d
  SEC Form 4 filed by Director Kozick Linda

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 431d
  SEC Form 4 filed by Director Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 431d
  SEC Form 4 filed by Director Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 489d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 489d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 489d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 489d
  SEC Form 4 filed by PRESIDENT AND CEO Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 518d
  New insider Medicxi Ventures Management (Jersey) Ltd claimed ownership of 22,352,000 shares (SEC Form 3)

  3 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 532d
  Former 10% Owner Column Group Ii, Lp disposed of 2,951,425 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 532d
  Former 10% Owner Column Group Ii, Lp disposed of 2,951,425 shares (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 569d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 569d
  SEC Form 4 filed by PRESIDENT AND CEO Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 569d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 569d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Rieflin William Jl

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Lyons-Williams Lori

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Kozick Linda

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 746d
  SEC Form 4 filed by Giordano Michael F

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 798d
  SEC Form 4 filed by Robbins Wendye

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 798d
  SEC Form 4 filed by Gray Mary Ann

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 798d
  SEC Form 4 filed by Rieflin William Jl

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 857d
  SEC Form 4 filed by Ho William

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 857d
  SEC Form 4 filed by Young Rodney Kb

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 857d
  SEC Form 4 filed by Brockstedt Dirk G.

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 857d
  SEC Form 4 filed by Wong Brian Russell

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 882d
  Brockstedt Dirk G. sold $20,456 worth of shares (898 units at $22.78), decreasing direct ownership by 3% to 27,820 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 888d
  Brockstedt Dirk G. exercised 8,000 shares at a strike of $6.18, increasing direct ownership by 42% to 27,070 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 899d
  Ho William sold $54,200 worth of shares (2,500 units at $21.68), decreasing direct ownership by 14% to 15,020 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 922d
  Ho William sold $20,580 worth of shares (1,500 units at $13.72), decreasing direct ownership by 8% to 17,520 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 978d
  Ho William sold $39,425 worth of shares (2,500 units at $15.77), decreasing direct ownership by 12% to 18,789 units (SEC Form 4)

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1021d
  SEC Form 4: Ho William sold $47,300 worth of shares (2,500 units at $18.92), decreasing direct ownership by 11% to 21,289 units

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)
• 1040d
  SEC Form 4: Ho William exercised 460 shares at a strike of $12.00, increasing direct ownership by 2% to 23,789 units

  4 - RAPT Therapeutics, Inc. (0001673772) (Issuer)